Gabriel Arefalk

942 total citations
7 papers, 100 citations indexed

About

Gabriel Arefalk is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Gabriel Arefalk has authored 7 papers receiving a total of 100 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 2 papers in Physiology and 1 paper in Health, Toxicology and Mutagenesis. Recurrent topics in Gabriel Arefalk's work include Heart Failure Treatment and Management (3 papers), Cardiovascular Function and Risk Factors (2 papers) and Acute Myocardial Infarction Research (2 papers). Gabriel Arefalk is often cited by papers focused on Heart Failure Treatment and Management (3 papers), Cardiovascular Function and Risk Factors (2 papers) and Acute Myocardial Infarction Research (2 papers). Gabriel Arefalk collaborates with scholars based in Sweden and Australia. Gabriel Arefalk's co-authors include Johan Sundström, Karl Michaëlsson, Lars Lind, Bertil Lindahl, Kristina Hambræus, Johan Ärnlöv, Olof Nyrén, Erik Ingelsson, Mats Lambe and Weimin Ye and has published in prestigious journals such as Circulation, American Heart Journal and Journal of Hypertension.

In The Last Decade

Gabriel Arefalk

6 papers receiving 90 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gabriel Arefalk Sweden	3	68	38	32	30	14	7	100
Hugo Pomares‐Millan United States	5	29 0.4×	26 0.7×	22 0.7×	5 0.2×	4 0.3×	15	109
Juliana Almeida‐de‐Souza Portugal	6	20 0.3×	41 1.1×	64 2.0×	3 0.1×	5 0.4×	11	134
Philip Dingli Malta	4	12 0.2×	27 0.7×	7 0.2×	7 0.2×	8 0.6×	10	64
Teresa Haugsgjerd Norway	7	34 0.5×	46 1.2×	38 1.2×	2 0.1×	2 0.1×	12	127
Gabrielle L. Onorato Italy	5	31 0.5×	16 0.4×	4 0.1×	31 1.0×	7 0.5×	7	107
Bartosz Miazgowski Poland	6	44 0.6×	35 0.9×	37 1.2×	2 0.1×	2 0.1×	10	115
Ana Luiza Lima Souza Brazil	6	24 0.4×	36 0.9×	13 0.4×	2 0.1×	8 0.6×	12	113
Emily Gray New Zealand	7	23 0.3×	45 1.2×	8 0.3×	2 0.1×	27 1.9×	16	97
Mark Sherman Canada	6	47 0.7×	27 0.7×	21 0.7×	2 0.1×	4 0.3×	11	113
Virginia Almadana Pacheco Spain	7	42 0.6×	10 0.3×	8 0.3×	4 0.1×	76 5.4×	32	127

Countries citing papers authored by Gabriel Arefalk

Since Specialization

Citations

This map shows the geographic impact of Gabriel Arefalk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Arefalk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Arefalk more than expected).

Fields of papers citing papers by Gabriel Arefalk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriel Arefalk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Arefalk. The network helps show where Gabriel Arefalk may publish in the future.

Co-authorship network of co-authors of Gabriel Arefalk

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriel Arefalk. A scholar is included among the top collaborators of Gabriel Arefalk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriel Arefalk. Gabriel Arefalk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Gustafsson, Stefan, Erik Lampa, Thomas Cars, et al.. (2024). Usefulness of Heart Failure Categories Based on Left Ventricular Ejection Fraction. Journal of the American Heart Association. 13(8). e032257–e032257. 6 indexed citations

2.

Gustafsson, Stefan, et al.. (2023). Usefulness of heart failure categories based on left ventricular ejection fraction. European Journal of Preventive Cardiology. 30(Supplement_1).

3.

Alfredsson, Joakim, Stefan James, David Erlinge, et al.. (2021). Randomized comparison of early supplemental oxygen versus ambient air in patients with confirmed myocardial infarction: Sex-related outcomes from DETO2X-AMI. American Heart Journal. 237. 13–24. 2 indexed citations

4.

Arefalk, Gabriel, Maria Rosaria Galanti, Michael Lundberg, et al.. (2018). Smokeless Tobacco (Snus) and Risk of Heart Failure of Ischemic and Non-Ischemic Origin: a Pooled Analysis of Eight Prospective Cohort Studies. 2 indexed citations

5.

Arefalk, Gabriel, Kristina Hambræus, Lars Lind, et al.. (2014). Discontinuation of Smokeless Tobacco and Mortality Risk After Myocardial Infarction. Circulation. 130(4). 325–332. 50 indexed citations

6.

Arefalk, Gabriel, Maria‐Pia Hergens, Erik Ingelsson, et al.. (2011). Smokeless tobacco (snus) and risk of heart failure: results from two Swedish cohorts. European Journal of Preventive Cardiology. 19(5). 1120–1127. 39 indexed citations

7.

Arefalk, Gabriel, Erik Ingelsson, Johan Ärnlöv, et al.. (2010). SMOKELESS TOBACCO (SNUS) AND RISK OF HEART FAILURE IN TWO SWEDISH COHORTS: PP.1.06. Journal of Hypertension. 28. e48–e49. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact